RSV disease severity compared to COVID-19 and influenza in hospitalized older adults
Study compares RSV severity to COVID-19 and flu in hospitalized older adults
An observational report from the IVY Network across 20 U.S. states examined disease severity among hospitalized adults aged ≥60 years with R…
A new report compares how serious respiratory syncytial virus is for hospitalized older adults against hospital stays for COVID-19 and the f…
Field report describes nirsevimab rollout for RSV prevention in New York City infants
How many New York City infants got the new RSV shot this season?
A field report describes the rollout of nirsevimab for RSV prevention in infants born during the recommended administration period in New Yo…
New York City health officials released an early look at how many eligible infants received the new RSV shot this season.
RSV Immunization Coverage Among US Infants Receiving Nirsevimab or Maternal Vaccination
How many infants are getting new RSV protection? A first look.
An observational report describes RSV immunization coverage among US infants born from October 2023 to March 2024 who received nirsevimab mo…
For the first time, doctors have tools to protect youngest babies from RSV with new shots or pregnancy vaccines.